EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Modern therapies: Nanotechnology promises new approaches for rare breast cancer brain metastases

Ghazala Muteeb, Aya Y El-Sayed, Mohamed S AboHoussien, Rawan H Abuelnile, Ahmed H Shaaban, Joud Ibrahim A Jaafari, Sheeba Kumari, Mohd Farhan, Mohammad Aatif, Doaa S R Khafaga

SLAS Discovery · 2026

DOI: 10.1016/j.slasd.2026.100331 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift SLAS Discovery, 2026. Verfasst von Ghazala Muteeb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, College of Applied Medical Sciences, King Faisal University, Al-Ahsa, 31982, Saudi Arabia. Electronic address: graza@kfu.edu.s…. Hauptthemen laut MEDLINE: Brain Neoplasms, Breast Neoplasms, Nanotechnology. Die Arbeit nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Faisal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain metastasis originating from breast cancer is an uncommon but clinically significant complication that poses substantial therapeutic challenges and is associated with poor patient prognosis. Traditional treatment modalities-including surgical resection, whole-brain radiation therapy, stereotactic radiosurgery, and systemic chemotherapy-often fail to achieve satisfactory long-term control due to the protective nature of the blood-brain barrier (BBB), tumor heterogeneity, and the aggressive biology of metastatic lesions. This comprehensive review delves into recent advances in modern therapeutic approaches that aim to enhance the efficacy of conventional treatments for rare brain metastases from breast cancer (BC). We systematically evaluate emerging strategies such as advanced drug delivery technologies, including nanoparticles (NPs), polymeric NPs, and liposomal formulations, which are designed to overcome pharmacokinetic limitations and improve the penetration and retention of chemotherapeutic agents within the central nervous system (CNS). The review also explores the integration of immunotherapies, particularly immune checkpoint inhibitors and adoptive cell therapies-with traditional modalities to potentiate antitumor immune responses in the brain microenvironment. Moreover, we discuss the development and application of novel radiosensitizers and combination regimens aimed at overcoming the inherent and acquired radioresistance of metastatic tumors. The synthesis of current preclinical models and clinical trial data provides critical insights into the potential of these combined approaches to enhance patient survival and quality of life. Finally, we identify key challenges, including the need for personalized treatment protocols and the management of therapy-related toxicities, and propose future directions for research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsBreast NeoplasmsNanotechnologyHumansFemaleNanoparticlesBlood-Brain BarrierDrug Delivery SystemsAnimalsAntineoplastic AgentsNanomedicineCombined Modality TherapyImmunotherapy

Stichwörter der Autor:innen

Brain metastasesBreast cancerDrug deliveryNanomedicineNanoparticle

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Nursing, College of Applied Medical Sciences, King Faisal University, Al-Ahsa, 31982, Saudi Arabia. Electronic address: graza@kfu.edu.sa.
  • Faculty of Medicine, Kasr Alainy, Cairo University, Cairo, Egypt.
  • Faculty of Medicine, Galala University, New Galala City, Suez, 43511, Egypt; OmicX Labs Agency, Cairo, 11715, Egypt.
  • Faculty of Science, Galala University, New Galala City, Suez, 43511, Egypt.
  • Department of Biology, Faculty of Science, Galala University, New Galala City, Suez, 43511, Egypt.
  • Department of Nursing, College of Applied Medical Sciences, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.

Förderung

  • King Faisal University

Zitieren

APA

Muteeb, G., El-Sayed, A. Y., AboHoussien, M. S., Abuelnile, R. H., Shaaban, A. H., Jaafari, J. I. A., Kumari, S., Farhan, M., Aatif, M., & Khafaga, D. S. R. (2026). Modern therapies: Nanotechnology promises new approaches for rare breast cancer brain metastases. SLAS Discovery. https://doi.org/10.1016/j.slasd.2026.100331

Vancouver

Muteeb G, El-Sayed AY, AboHoussien MS, Abuelnile RH, Shaaban AH, Jaafari JIA, et al. Modern therapies: Nanotechnology promises new approaches for rare breast cancer brain metastases. SLAS Discovery. 2026. doi:10.1016/j.slasd.2026.100331

BibTeX
@article{Muteeb2026,
  author = {Muteeb, Ghazala and El-Sayed, Aya Y and AboHoussien, Mohamed S and Abuelnile, Rawan H and Shaaban, Ahmed H and Jaafari, Joud Ibrahim A and Kumari, Sheeba and Farhan, Mohd and Aatif, Mohammad and Khafaga, Doaa S R},
  title = {Modern therapies: Nanotechnology promises new approaches for rare breast cancer brain metastases},
  journal = {SLAS Discovery},
  year = {2026},
  doi = {10.1016/j.slasd.2026.100331}
}
Kostenlos starten →